MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-CH-01-0024540
Singlamedicos Pharma Solutions Private Limited
Singlamedicos Pharma Solutions Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹120.59 Cr
▲ 26% YoY
Net loss · FY 2025
₹62.04 Lakh
Net margin -0.5%
EBITDA · FY 2025
₹1.93 Cr
EBITDA margin 1.6%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹26.6 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Employees · EPFO
37
Provident fund records
About Singlamedicos Pharma Solutions Private Limited
Data last updated:
Singlamedicos Pharma Solutions Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 March 2022.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909CH2022PTC044275. Its GSTIN is 04ABICS1203R1Z8 (Chandigarh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Arvind Kumar Venkat and Viejay Kumar Singla.
Its last annual general meeting (AGM) was held on 24 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 53 54 55, Second Floor Sector 17D, Chandigarh, India – 160017.
As per the financials filed for FY 2025, the company reported a revenue of ₹120.59 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net loss of ₹62.04 Lakh (net margin -0.5%) and EBITDA of ₹1.93 Cr (EBITDA margin 1.6%).
The company has about 37 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹26.6 Cr on record.
Singlamedicos Pharma Solutions Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-CH-01-0024540). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909CH2022PTC044275
Registration Number 044275
Incorporation Date 25 March 2022
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-CH-01-0024540
Recognitions & Rankings of Singlamedicos Pharma Solutions
Contact details
Singlamedicos Pharma Solutions Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO 53 54 55, Second Floor Sector 17D, Chandigarh, India – 160017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Singlamedicos Pharma Solutions Private Limited, buy the company report.
Comprehensive company report
Singlamedicos Pharma Solutions Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Singlamedicos Pharma Solutions is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Singlamedicos Pharma Solutions Private Limited, buy the company report.
Financials of Singlamedicos Pharma Solutions Private Limited
FY 2025 filings availableSinglamedicos Pharma Solutions Private Limited reported revenue of ₹120.59 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹120.59 Cr ▲ 26%
Net loss · FY 2025
₹62.04 Lakh margin -0.5%
EBITDA · FY 2025
₹1.93 Cr margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
EBITDA CAGR growth
1 year
▲ 38%
Revenue rose 26% in the latest year. EBITDA rose 38% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.93 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹62.04 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.6% | |||
| Net Profit Margin | -0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Singlamedicos Pharma Solutions Private Limited, buy the company report.
Board of directors of Singlamedicos Pharma Solutions Private Limited
Singlamedicos Pharma Solutions has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Venkat | Director | 28 Feb 2025 | 1 Years 8 Months | Current |
| Viejay Kumar Singla | Director | 25 Mar 2022 | 4 Years 7 Months | Current |
| Rajat Sngla | Director | 14 Jun 2023 | 3 Years 4 Months | Current |
| Gaurav Chaturvedi | Director | 09 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Singlamedicos Pharma Solutions Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jaggi Enterprises Private Limited | ₹123.9 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Kaafi Enterprises Private Limited | ₹122.9 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| B M Chemie Private Limited | ₹121.23 Cr (FY 2025) | 2752.0% | Mumbai, Maharashtra, India | |||
| Shri Bhakti Medical Agencies Private Limited | ₹120.88 Cr (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Singlamedicos Pharma Solutions Private Limitedthis company | ₹120.59 Cr (FY 2025) | -₹62.04 Lakh | -0.5% | 26.0% | 37 | Chandigarh, India |
| Raivat Impex Private Limited | ₹118.54 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Vasu Pharma Drugs Private Limited | ₹117.34 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Kasiviswanathan Medical Agencies Private Limited | ₹116.03 Cr (FY 2025) | 11.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Singlamedicos Pharma Solutions Private Limited, buy the company report.
Auditor
Singlamedicos Pharma Solutions Private Limited is audited by GOEL ARUN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOEL ARUN & ASSOCIATES | FY 2023 | 523071 |
Shareholding
The shareholding of Singlamedicos Pharma Solutions Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Singlamedicos Pharma Solutions Private Limited, buy the company report.
Charges & borrowings
Open charges
₹26.6 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Dec 2025 | 101204127 | Hdfc Bank Limited | ₹1.6 Cr | Open | |
| 20 May 2023 | 100730836 | Hdfc Bank Limited | ₹25 Cr | Open |
To see the full charge records of Singlamedicos Pharma Solutions Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Singlamedicos Pharma Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Singlamedicos Pharma Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Singlamedicos Pharma Solutions Private Limited has a workforce of 37 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
37
Active EPFO establishments
1
Employee growth
-5.13%
GST
Singlamedicos Pharma Solutions has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04ABICS1203R1Z8 | Chandigarh | Active | 27 Sep 2022 |
To see the full GST registrations and return filing status of Singlamedicos Pharma Solutions Private Limited, buy the company report.
Recent activity
Singlamedicos Pharma Solutions Private Limited has 8 board changes on record since 2022: 4 appointments and 4 cessations. The latest: Arvind Kumar Venkat ceased to be Additional Director on 23 Jun 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 160.00 Lakh with Charge ID 101204127 was registered on 10 Dec 2025.
AGM
Singlamedicos Pharma Solutions Private Limited last Annual general meeting of members was held on 24 Jun 2025 as per latest MCA records.
Ceased
Arvind Kumar Venkat ceased to be Additional Director.
Filing
Singlamedicos Pharma Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Arvind Kumar Venkat was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 2,500.00 Lakh registered on 20 May 2023 with Charge ID 100730836 was modified on 05 Dec 2024.
Ceased
Gaurav Chaturvedi ceased to be Additional Director.
Appointed
Gaurav Chaturvedi was appointed as Director.
Ceased
Rajat Sngla ceased to be Additional Director.
Appointed
Rajat Sngla was appointed as Director.
Ceased
Gian Chand Singla ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2,500.00 Lakh with Charge ID 100730836 was registered on 20 May 2023.
2 earlier events are in the company report.
Frequently asked questions
Singlamedicos Pharma Solutions is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 March 2022 (4+ years old) and is registered under CIN U51909CH2022PTC044275.
Singlamedicos Pharma Solutions has 4 current directors:
- Arvind Kumar Venkat - Director
- Viejay Kumar Singla - Director
- Rajat Sngla - Director
- Gaurav Chaturvedi - Director
The latest financial statements of Singlamedicos Pharma Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 June 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Singlamedicos Pharma Solutions is 04ABICS1203R1Z8, registered in Chandigarh.
The CIN (Corporate Identification Number) of Singlamedicos Pharma Solutions is U51909CH2022PTC044275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Singlamedicos Pharma Solutions was incorporated on 25 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Singlamedicos Pharma Solutions by revenue are Jaggi Enterprises Private Limited, Kaafi Enterprises Private Limited, B M Chemie Private Limited, Shri Bhakti Medical Agencies Private Limited, Raivat Impex Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Arvind Kumar Venkat ceased to be Additional Director on 23 Jun 2025. Arvind Kumar Venkat was appointed as Director on 28 Feb 2025. Gaurav Chaturvedi ceased to be Additional Director on 22 Sep 2024. Singlamedicos Pharma Solutions has 8 board changes on record in total.
Yes, Singlamedicos Pharma Solutions is registered as an MSME under Udyam registration (number: UDYAM-CH-01-0024540).
The registered office of Singlamedicos Pharma Solutions is at SCO 53 54 55, Second Floor Sector 17D, Chandigarh, India – 160017.
Singlamedicos Pharma Solutions operates in the pharma industry, in the pharmaceutical retailers and distributors segment.